Literature DB >> 30440082

Caries prevalence and associations with medications and medical comorbidities.

M Marianne Jurasic1,2, Gretchen Gibson3, Carolyn J Wehler2,1, Michelle B Orner2, Judith A Jones2,4.   

Abstract

OBJECTIVES: To use extensive electronic dental, medical, and pharmacy databases to estimate the prevalence of dental caries in a cohort of new patients during a 5-year period (FY2010-FY2015) and determine whether medication use and medical comorbidities are associated with caries prevalence.
METHODS: This was a retrospective analysis of existing data from the Department of Veterans Affairs (VA). The number of teeth treated due to a caries-related diagnosis was determined and outcomes were presented as number of teeth/person and proportion of patients receiving caries-related treatment. Logistic and negative binomial regression modeled teeth/person with caries-related treatment; covariates included age, gender, race, ethnicity, physical and mental comorbidities, and use of prescription medications and prescription drugs with strong anticholinergic properties.
RESULTS: The study population included 95,850 dentate dental patients: 92.1 percent were male, mean age of 58.7 ± 12.6 years, 73.2 percent were White/Caucasian, and 21.3 percent were Black/African American. They were taking a mean of 10.6 ± 5.9 VA prescription drug classes, 0.6 ± 0.4 drugs with strong anticholinergic properties, and had 3.6 ± 2.2 physical and 1.4 ± 1.2 mental comorbidities. On average, 2.2 teeth/person received caries-related treatment and 58 percent of the study population received any caries-related treatment. An increase in the rate of caries-related treatment in Veterans was statistically significantly associated with increased prescription medication use; one or more drugs with strong anticholinergic properties and with 1+ mental comorbidities. Increased physical comorbidity was not statistically significantly associated with caries-related treatment.
CONCLUSIONS: This study demonstrates a high prevalence of caries among Veteran dental patients, with an increased prevalence in those taking higher numbers of prescription medications.
© 2018 American Association of Public Health Dentistry.

Entities:  

Keywords:  anticholinergic; comorbidity; dental caries; electronic health records; medication; prevalence

Mesh:

Year:  2018        PMID: 30440082     DOI: 10.1111/jphd.12292

Source DB:  PubMed          Journal:  J Public Health Dent        ISSN: 0022-4006            Impact factor:   1.821


  5 in total

1.  Caries Risk Prediction Models in a Medical Health Care Setting.

Authors:  T A Kalhan; C Un Lam; B Karunakaran; P L Chay; C K Chng; R Nair; Y S Lee; M C F Fong; Y S Chong; K Kwek; S M Saw; L Shek; F Yap; K H Tan; K M Godfrey; J Huang; C-Y S Hsu
Journal:  J Dent Res       Date:  2020-04-20       Impact factor: 6.116

2.  Anticholinergic medication and dental caries status in middle-aged xerostomia patients-a retrospective study.

Authors:  Mayank Kakkar; Abdul Basir Barmak; Szilvia Arany
Journal:  J Dent Sci       Date:  2021-12-29       Impact factor: 3.719

3.  Topical Fluoride Effectiveness in High Caries Risk Adults.

Authors:  M M Jurasic; G Gibson; M B Orner; C J Wehler; J A Jones; H J Cabral
Journal:  J Dent Res       Date:  2022-03-09       Impact factor: 8.924

Review 4.  Anticholinergic medication: Related dry mouth and effects on the salivary glands.

Authors:  Szilvia Arany; Dorota T Kopycka-Kedzierawski; Thomas V Caprio; Gene E Watson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2021-08-29

5.  Concordance of antibiotic prescribing with the American Dental Association acute oral infection guidelines within Veterans' Affairs (VA) dentistry.

Authors:  Daniel B Carlsen; Michael J Durkin; Gretchen Gibson; M Marianne Jurasic; Ursula Patel; Linda Poggensee; Margaret A Fitzpatrick; Kelly Echevarria; Jessina McGregor; Charlesnika T Evans; Katie J Suda
Journal:  Infect Control Hosp Epidemiol       Date:  2021-03-02       Impact factor: 3.254

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.